Is Itraconazole Safe? Heart, Liver, and Drug Risks

Itraconazole is generally safe for most people when used as directed, but it carries two FDA boxed warnings (the most serious type) for heart effects and liver damage. In clinical trials, about 28% of patients experienced at least one side effect. For the majority, these were mild and temporary, but the drug does require caution in specific groups and interacts dangerously with a long list of other medications.

Common Side Effects

In a study of 227 patients, the most frequent problems were liver enzyme elevations (7%), nausea or vomiting (6.6%), and diarrhea (6.2%). Other reported side effects in adults include fatigue, rash, itching, and headache. Most of these resolve after stopping the medication or finishing the course of treatment.

Pulse therapy, where you take itraconazole for one week per month rather than continuously, tends to be better tolerated. In a pediatric study following patients for up to four years after starting pulse treatment for nail fungus, none experienced clinical side effects. The reduced total number of days on the drug lowers cumulative exposure and the chance of problems.

The Heart Warning

Itraconazole has a negative inotropic effect, meaning it reduces the force of your heart’s contractions. The exact mechanism isn’t fully understood, though animal studies point to either mitochondrial dysfunction in heart cells or a direct effect on heart muscle contraction and heart rate. Either way, the result is the same: the heart pumps less effectively.

For someone with a healthy heart, this effect is unlikely to cause noticeable problems. But if you have heart failure, a history of heart failure, or other forms of ventricular dysfunction, itraconazole can make your condition significantly worse. The FDA states it should not be used for nail fungus in patients with any evidence of ventricular dysfunction. If you develop shortness of breath, swelling in your legs, unusual fatigue, or rapid weight gain while taking itraconazole, those are signs the drug may be affecting your heart.

The Liver Warning

Itraconazole has been linked to rare but serious liver injury, including liver failure and death. What makes this particularly concerning is that some cases occurred in people with no pre-existing liver disease and no other serious medical conditions. In some patients, liver damage appeared within the first week of treatment.

If you develop symptoms like unusual fatigue, dark urine, pale stools, loss of appetite, nausea, or yellowing of the skin or eyes, these could signal liver trouble. The FDA’s guidance is blunt: once liver problems develop, restarting itraconazole “is strongly discouraged unless there is a serious or life-threatening situation where the expected benefit exceeds the risk.”

Drug Interactions Are Extensive

This is where itraconazole demands the most attention. It blocks a key enzyme system in the liver that processes many other medications, causing those drugs to build up to potentially dangerous levels in your blood. It also interferes with a transport protein that helps move drugs through your body. The combination means itraconazole interacts with an unusually large number of medications.

Drugs that are strictly off-limits while taking itraconazole include:

  • Heart rhythm medications: quinidine, dofetilide, dronedarone, disopyramide, ranolazine
  • Cholesterol drugs: lovastatin, simvastatin
  • Sedatives: oral midazolam, triazolam
  • Blood pressure drugs: felodipine, nisoldipine
  • Other: methadone, pimozide, ergot alkaloids (used for migraines), certain blood thinners like ticagrelor

The risk with many of these combinations is a dangerous heart rhythm called torsades de pointes, where the heart beats so irregularly it can be fatal. This isn’t a theoretical concern. Any medication that is processed by the same liver enzyme and can affect heart rhythm becomes potentially lethal when paired with itraconazole. Before starting treatment, make sure your prescriber has a complete list of everything you take, including supplements.

Absorption Depends on Stomach Acid

Itraconazole capsules need an acidic stomach environment to dissolve and absorb properly. If you take antacids, proton pump inhibitors (like omeprazole), or H2 blockers (like famotidine), your body may absorb significantly less of the drug. This doesn’t just reduce effectiveness; inconsistent absorption can complicate dosing.

The capsules should be taken immediately after a full meal, which naturally stimulates stomach acid production. If you need to take antacids, space them at least two hours before or after your itraconazole dose. An interesting finding from studies in AIDS patients with very low stomach acid: drinking a non-diet cola with the capsules improved absorption, likely because the acidity of the beverage partially compensated for the lack of gastric acid. The oral solution form of itraconazole does not have this same absorption problem.

Pregnancy and Breastfeeding

Itraconazole is not recommended during pregnancy. For breastfeeding, no clinical studies have directly evaluated its safety, but limited data suggest the amount that passes into breast milk is low. A fully breastfed infant between 3 and 12 months old would receive roughly 1.5% of the mother’s weight-adjusted dose, and the infant’s resulting blood levels would be less than 1% of the mother’s. Even so, an alternative antifungal is generally preferred, especially for newborns or preterm infants. If itraconazole is necessary during breastfeeding, monitoring the infant’s liver function is a reasonable precaution during longer courses.

Who Should Be Most Cautious

The safety profile of itraconazole is manageable for most healthy adults taking it for a defined course. The people who face real risk are those with heart failure or weakened heart function, existing liver disease, low stomach acid (which affects how much drug actually enters the body), and anyone taking multiple medications that pass through the same liver enzyme pathway.

For nail fungus and other non-life-threatening infections, the bar for acceptable risk is higher. The FDA specifically distinguishes between using itraconazole for serious systemic fungal infections, where the benefit clearly justifies the risks, and cosmetic concerns like nail fungus, where it shouldn’t be used if heart problems are present. If you’re healthy and taking a short or pulsed course, the drug has a solid track record. If you have heart or liver concerns, the conversation with your prescriber should be direct about whether the benefit is worth it.